Respiratory Oxygen Delivery Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Oxygen Masks, Nasal Cannula, Venturi Masks, Non-rebreather Masks, Bag Valve Masks, CPAP Masks, Others), By End-use (Hospitals, Outpatient Facilities, Home Care, Others), By Region, and By Competition, 2020-2030F

Market Overview

The Global Respiratory Oxygen Delivery Devices Market, valued at USD 13.18 Billion in 2024, is projected to experience a CAGR of 7.91% to reach USD 20.81 Billion by 2030. Respiratory oxygen delivery devices encompass a range of medical equipment designed to administer supplemental oxygen to patients experiencing respiratory insufficiency or hypoxemia. Key drivers supporting market expansion include the escalating global prevalence of chronic respiratory diseases, a growing geriatric population highly susceptible to such conditions, and continuous advancements in device technology enhancing portability and user-friendliness. According to the American Lung Association, in 2023, approximately 11.1 million adults in the United States were living with Chronic Obstructive Pulmonary Disease (COPD), a primary indicator for oxygen therapy.

A significant impediment to market growth, particularly in emerging economies, is the substantial cost associated with advanced oxygen therapy equipment, which can limit widespread adoption and accessibility.

Key Market Drivers

The increasing prevalence of chronic respiratory diseases significantly propels the global respiratory oxygen delivery devices market. Conditions such as Chronic Obstructive Pulmonary Disease, asthma, and interstitial lung diseases often necessitate supplemental oxygen therapy to manage symptoms and improve patient quality of life. The escalating global burden of these illnesses directly translates into a higher demand for both stationary and portable oxygen systems. According to the World Health Organization, in November 2024, over 380 million people globally were affected by Chronic Obstructive Pulmonary Disease, underscoring the substantial patient population requiring respiratory support. This widespread need drives innovation and production in oxygen delivery technologies, including cannulas, masks, and concentrators.

Concurrently, global aging population demographics represent another critical driver for this market. As the worldwide population ages, there is an inherent increase in the incidence of age-related respiratory conditions and the exacerbation of pre-existing chronic diseases, leading to a greater reliance on oxygen therapy. Older adults are more susceptible to severe respiratory infections and chronic lung conditions, which frequently require long-term oxygen supplementation. According to the United Nations Population Fund, in June 2024, the worldwide share of people aged 65 almost doubled between 1974 and 2024, increasing from 5.5 percent to 10.3 percent, indicating a rapidly expanding demographic prone to respiratory ailments. This demographic shift ensures a sustained and growing patient base for respiratory oxygen delivery devices. The overall market for these vital medical products continues to expand, reflecting these fundamental trends. According to Philips Healthcare, in February 2025, their Connected Care segment, which includes respiratory care, reported a 7% comparable sales increase in Q4 2024, demonstrating robust market activity.

Download Free Sample Report

Key Market Challenges

A significant impediment to the expansion of the Global Respiratory Oxygen Delivery Devices Market is the substantial cost associated with advanced oxygen therapy equipment. This financial burden directly restricts widespread adoption and accessibility, particularly within emerging economies. High equipment costs often exceed the constrained healthcare budgets of these regions, leading to under-resourced medical facilities and limited patient access to necessary care.

According to the World Health Organization's 2023 Global Health Expenditure Report, in 2021, low-income countries represented merely 0.24% of global health expenditure, despite comprising 8% of the world's population. This stark imbalance indicates severe limitations in public health investment, making it difficult for healthcare systems to procure expensive medical devices. Furthermore, the World Health Organization's 2024 Global Health Expenditure Report revealed that in 2022, out-of-pocket spending continued to be the main source of health financing in 30 low- and lower-middle-income countries, with patients directly funding over half of total health spending in 20 of these nations. Such significant reliance on direct patient payments severely impacts affordability, preventing many from acquiring vital oxygen delivery devices and thereby directly hindering market growth in these underserved areas.

Key Market Trends

The Global Respiratory Oxygen Delivery Devices Market is significantly shaped by technological advancements and evolving patient care paradigms. Two prominent trends demonstrating substantial influence are the enhanced portability and miniaturization of devices and the rise of AI-powered solutions for personalized therapy.

Enhanced portability and miniaturization of respiratory oxygen delivery devices represent a critical market trend, improving patient autonomy and quality of life. Smaller, lighter oxygen concentrators allow individuals requiring supplemental oxygen to maintain active lifestyles and reduce reliance on stationary equipment, thereby fostering greater patient adherence to therapy. The American Association for Respiratory Care consistently emphasizes the importance of patient mobility in long-term oxygen therapy, noting that increased device portability directly correlates with improved patient engagement outside the home. Manufacturers are actively responding to this demand, as evidenced by VARON's launch of the VP-8G portable oxygen concentrator in July 2025, which was specifically marketed for its lighter design and smart features aimed at active users globally. This innovation enables patients to travel and participate in daily activities more freely, expanding the market reach of these crucial medical products.

The rise of AI-powered solutions for personalized therapy is another transformative trend within the respiratory oxygen delivery devices market, promising more effective and adaptive patient care. Artificial intelligence allows for the analysis of individual patient data, including breathing patterns, oxygen saturation levels, and activity, to deliver customized oxygen flow and anticipate potential health issues. The American Thoracic Society frequently highlights the potential of AI to refine diagnostic accuracy and optimize treatment protocols in chronic respiratory diseases. A significant development in this area was observed in November 2023 when the U. S. startup Samay presented clinical findings for its Sylvee wearable technology, an AI-supported device that accurately identified "air trapping," a key early indicator of COPD exacerbations, with 83% accuracy. Such innovations enable proactive interventions and tailored oxygen delivery, potentially reducing exacerbation rates and improving overall patient outcomes.

Segmental Insights

The Hospitals segment is a key and rapidly expanding area within the Global Respiratory Oxygen Delivery Devices Market. This accelerated growth is primarily attributed to the escalating prevalence of various respiratory diseases, including chronic obstructive pulmonary disease and acute respiratory infections, which necessitate hospital-based diagnosis and treatment. Furthermore, the continuous enhancement of critical care infrastructure and the adoption of technologically advanced oxygen delivery systems capable of precise and controlled therapy contribute significantly to this expansion. Regulatory oversight by bodies such as the World Health Organization ensures that devices used in hospitals meet stringent safety and quality standards, further supporting demand for compliant equipment in these essential healthcare facilities. The Hospitals segment stands as a key and rapidly expanding area within the Global Respiratory Oxygen Delivery Devices Market. This accelerated growth is primarily attributed to the escalating prevalence of various respiratory diseases, including chronic obstructive pulmonary disease, asthma, and acute respiratory infections, which necessitate hospital-based diagnosis and intensive treatment. Furthermore, the continuous enhancement of critical care infrastructure, coupled with the adoption of technologically advanced oxygen delivery systems capable of precise and controlled therapy, contributes significantly to this expansion. Regulatory oversight by bodies such as the World Health Organization ensures that devices used in hospitals meet stringent safety and quality standards, further supporting demand for compliant equipment in these essential healthcare facilities.

Regional Insights

Asia Pacific dominates the Global Respiratory Oxygen Delivery Devices Market due to a significant confluence of factors. The region faces a high burden of respiratory conditions, including chronic obstructive pulmonary disease and asthma, exacerbated by rising air pollution levels and changing lifestyles. Simultaneously, a rapidly expanding geriatric population, highly susceptible to these illnesses, further drives demand for oxygen delivery solutions. Robust investments in healthcare infrastructure and technological advancements are improving access to respiratory care across urban and rural areas. Moreover, government initiatives promoting healthcare accessibility and managing chronic respiratory diseases, alongside increasing demand for home-based oxygen therapy, contribute to the region's strong market leadership.

Recent Developments

• In January 2025, Southmedic Incorporated and OxyNov announced a strategic partnership aimed at enhancing oxygen delivery across Canada. This collaboration integrates Southmedic's Oxy2Mask™ with OxyNov's FreeO2™ system, combining a versatile oxygen mask known for its open design and broad flow rates with automated oxygen titration technology. The joint offering seeks to provide a safer, more cost-effective, and labor-efficient solution for patients, optimizing oxygen therapy by continuously monitoring and adjusting flow based on patient saturation levels.

• In October 2024, Inogen, Inc. introduced the Inogen® Rove 4™ Portable Oxygen Concentrator to the U.S. market. This new portable oxygen delivery device features an additional, fourth flow setting capable of providing up to 840 ml/min of medical-grade oxygen. Designed for patient mobility, the Rove 4 weighs less than 3 pounds and incorporates Inogen's patented Intelligent Delivery Technology®. This technology ensures sensitive breath detection and delivers oxygen within the initial milliseconds of inspiration, thereby optimizing lung gas exchange for users.

• In August 2024, Fisher & Paykel Healthcare Corporation Limited launched its F&P my820 System in the United States. This new respiratory humidifier is designed for home mechanical ventilation, providing heated humidification for adult and pediatric patients receiving invasive, noninvasive, and humidified high-flow therapies. The F&P my820 System incorporates an integrated sensor that automatically adjusts to ambient temperature fluctuations, which helps in mitigating circuit condensate and simplifies the setup process for home care users.

• In May and July 2024, Inspira Technologies OXY B.H.N. received FDA 510(k) clearance and Israeli AMAR certification, respectively, for its INSPIRA™ ART100 system. This breakthrough Augmented Respiration Technology (ART) device is designed for use in cardiopulmonary bypass procedures, representing a significant advancement in respiratory support. The technology aims to elevate and stabilize oxygen saturation levels without a mechanical ventilator, potentially offering an alternative for patients with acute respiratory failure by enabling them to remain awake during treatment.

Key Market Players

• GE Healthcare Technologies Inc
• Koninklijke Philips NV
• ICU Medical Group Ltd (Smiths Medical Group Ltd)
• Invacare Corp
• Medtronic PLC
• Fisher & Paykel Healthcare Limited
• ResMed Inc
• CAIRE Inc
• Linde Plc
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Report Scope:

In this report, the Global Respiratory Oxygen Delivery Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Respiratory Oxygen Delivery Devices Market, By Product:

o   Oxygen Masks

o   Nasal Cannula

o   Venturi Masks

o   Non-rebreather Masks

o   Bag Valve Masks

o   CPAP Masks

o   Others

• Respiratory Oxygen Delivery Devices Market, By End User:

o   Hospitals

o   Outpatient Facilities

o   Home Care

o   Others

• Respiratory Oxygen Delivery Devices Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Respiratory Oxygen Delivery Devices Market.

Available Customizations:

Global Respiratory Oxygen Delivery Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Respiratory Oxygen Delivery Devices Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]